7 minute Hepatology cover art

7 minute Hepatology

7 minute Hepatology

Written by: Rohit Gupta
Listen for free

Clinical discussion of all things hepatology. All of the things you wish you could ask a world expert and clinical pearls that you won't find in a text book. An Australian based clinical education podcast.Rohit Gupta Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • Which systemic therapy should I choose for HCC?
    Oct 16 2026

    Join Prof Ken Liu as we discuss the ins and outs of choosing different systemic therapy of HCC.


    Check out EASL Deepdive: https://open.spotify.com/episode/3QlE3JUpMjyGYCifmtHWyp


    Article discussed today: Immune checkpoint inhibitor-related hepatotoxicity: A review
    Remash D, Prince DS, McKenzie C, Strasser SI, Kao S, Liu K. Immune checkpoint inhibitor-related hepatotoxicity: A review. World J Gastroenterol 2021; 27(32): 5376-5391 [PMID: 34539139 DOI: 10.3748/wjg.v27.i32.5376]


    https://www.wjgnet.com/1007-9327/full/v27/i32/5376.htm


    Show More Show Less
    12 mins
  • When should I refer to palliative care for patients with cirrhosis?
    Sep 4 2026

    Join Dr Richard Skoien and Dr Alison Kearney as we discuss the Hepatocare model and the importance of appropriate and timely palliative care referral.


    Scottish Guidelines:

    https://www.palliativecareguidelines.scot.nhs.uk/scottish-palliative-care-guidelines/last-days-of-life-care-around-dying/end-stage-liver-disease/


    Show More Show Less
    13 mins
  • When should I prescribe steroids for alcohol associated hepatitis?
    Aug 22 2026

    Join A/Prof Juan Pablo Arab as we discuss using steroids in alcohol associated hepatitis.


    Arab JP, Díaz LA, Baeza N, Idalsoaga F, Fuentes-López E, Arnold J, Ramírez CA, Morales-Arraez D, Ventura-Cots M, Alvarado-Tapias E, Zhang W, Clark V, Simonetto D, Ahn JC, Buryska S, Mehta TI, Stefanescu H, Horhat A, Bumbu A, Dunn W, Attar B, Agrawal R, Haque ZS, Majeed M, Cabezas J, García-Carrera I, Parker R, Cuyàs B, Poca M, Soriano G, Sarin SK, Maiwall R, Jalal PK, Abdulsada S, Higuera-de la Tijera MF, Kulkarni AV, Rao PN, Guerra Salazar P, Skladaný L, Bystrianska N, Prado V, Clemente-Sanchez A, Rincón D, Haider T, Chacko KR, Cairo F, de Sousa Coelho M, Romero GA, Pollarsky FD, Restrepo JC, Castro-Sanchez S, Toro LG, Yaquich P, Mendizabal M, Garrido ML, Narvaez A, Bessone F, Marcelo JS, Piombino D, Dirchwolf M, Arancibia JP, Altamirano J, Kim W, Araujo RC, Duarte-Rojo A, Vargas V, Rautou PE, Issoufaly T, Zamarripa F, Torre A, Lucey MR, Mathurin P, Louvet A, García-Tsao G, González JA, Verna E, Brown RS, Roblero JP, Abraldes JG, Arrese M, Shah VH, Kamath PS, Singal AK, Bataller R. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. J Hepatol. 2021 Nov;75(5):1026-1033. doi: 10.1016/j.jhep.2021.06.019. Epub 2021 Jun 21. PMID: 34166722; PMCID: PMC11090180.


    https://pubmed.ncbi.nlm.nih.gov/34166722/


    Show More Show Less
    9 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet